Search for: "Genentech, Inc." Results 1 - 20 of 469
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 May 2016, 7:04 pm by Consuella Pachico
Comanche County Memorial Hospital said San Francisco-based Genentech shortchanged hospitals by putting less Herceptin in the bottleThe post Genentech Inc., Sued For Cheating Providers appeared first on Legal Reader. [read post]
22 Dec 2022, 3:15 pm by Lawrence B. Ebert
The outcome: Genentech, Inc. and InterMune, Inc. [read post]
30 Mar 2020, 9:08 pm by Patent Docs
Noonan -- The Federal Circuit affirmed the Patent Trial and Appeal Board's (PTAB) claim construction (and inter partes review (IPR) decision invalidating claims for obviousness) in it recent Genentech, Inc. v. [read post]
22 Sep 2019, 8:54 pm by Patent Docs
Genentech, Inc., the Federal Circuit affirmed a decision by the U.S. [read post]
21 Feb 2008, 2:24 am
Glaxo Group Ltd v Genentech Inc and Another Court of Appeal “The approach to a stay in European patent cases differed from a stay in ordinary commercial litigation because the possibility of parallel validity proceedings in national courts and in the European Patent Office was inherent in the legal arrangements in the European Patent Convention. [read post]
28 Feb 2013, 6:01 am
Genentech, also known as "Genetic Engineering Technology, Inc." is a wholly owned subsidiary of F. [read post]
2 Aug 2007, 7:56 pm
Singer -- Genentech announced in an August 2, 2007 press release that the Hart-Scott-Rodino waiting period that applied to its acquisition of Tanox, Inc. has expired, and that the acquisition is now completed. [read post]
28 Dec 2011, 4:46 pm
San Diego - Genentech filed suit against Regeneron Pharmaceuticals and Sanofi Inc. on December 23, 2011 in the United States District Court, Southern District of New York. [read post]
7 Jul 2020, 8:22 pm by Patent Docs
Noonan -- In a procedurally unusual decision (but one unsurprising in all other respects), the Federal Circuit on Monday affirmed a district court's denial of a temporary restraining order to keep off the market Amgen's biosimilar product Mvasi in Genentech, Inc. v. [read post]